Risk v. reward: Washington Post asks if it's worth it when nonprofits (especially research-focused ones) "act like venture capitalists".
"The pioneering success of Beall and the Cystic Fibrosis Foundation in the practice of 'venture philanthropy' is prompting a growing number of nonprofit groups to explore whether they, too, might be able to benefit their patients, and bottom lines, by investing in similar ways.... Venture philanthropy has its skeptics, who argue that patient groups risk harming their reputations and their bank accounts by forming partnerships with the drug industry. Some experts worry that the relationships create inherent conflicts of interest and that nonprofits could allow financial motives to undermine their primary mission of putting patients first." -- Brady Dennis, the Washington Post
